header-news
Glaucoma drug to undergo new trials
Tuesday, 08 January 2008
Japan is to play host to a new phase II clinical trial of a medicine designed to treat patients with glaucoma.

Drug maker NicOx SA revealed that Pfizer has initiated a second study of PF-03187207, a drug the two firms created in collaboration, to examine its safety and efficacy.
Read more...
 
FDA gives orphan drug nod to Crohn's drug
Tuesday, 08 January 2008
The US Food and Drug Administration (FDA) has granted orphan drug designation to a medicine intended to help tackle paediatric Crohn's disease, drug maker DOR BioPharma has revealed.

Crohn's causes the tissue in the gastrointestinal tract to become inflamed, resulting in abdominal pain and diarrhoea.
Read more...
 
AIH drug trials launch
Friday, 04 January 2008
Phase II trials of a new drug designed to treat patients suffering with autoimmune hepatitis (AIH) have been launched.

LifeCycle Pharma said that LCP-Tacro will be tested at a maximum of 12 centres in the US and Canada, with around 60 patients expected to take part.
Read more...
 
AML drug begins phase II trials
Thursday, 03 January 2008
A phase II clinical trial of a new acute myeloid leukaemia (AML) drug designed for elderly patients has been initiated.

Cyclacel Pharmaceuticals said that oral sapacitabine is being studied to determine the survival rates of patients who have not been treated for the disease, or are experiencing their first relapse, when they are given one of three different doses of the drug.
Read more...
 
More...
<< Start < Prev 1 2 3 Next > End >>

Results 25 - 48 of 64